Locations: Addenbrooke’s Hospital, The Beatson, Royal Marsden Hospital, University College London, Christie Hospital
This study aims to find out how safe and effective the drug BT1718 is, as well as potential side effects in adult patients with advanced solid tumours. This clinical study has two phases. The first phase is a ‘dose escalation’ phase where groups of patients will receive increasing doses of BT1718 to find a safe dose that best targets the cancer cells. The second is an ‘expansion phase’ where larger groups of patients will be given the selected dose of BT1718 to allow us to find out more about how the drug is working. This study is now in the expansion phase.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.